Navigation Links
Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting
Date:12/10/2007

ivity during treatment with the combination.

In summary, these results appear to support and form the basis of testing the combination therapy of MGCD0103 and Vidaza in a larger randomized three-arm study which is currently being planned by the partners.

About MGCD0103

MGCD0103 is an orally-administered, isotype-selective HDAC inhibitor. The compound is currently in three Phase I/II clinical trials, in combination with Vidaza(R) for hematological malignances and with Gemzar(R) and Taxotere(R) in solid tumors; and in four Phase II monotherapy clinical trials in hematological malignancies.

About Vidaza

In May 2004, Vidaza became the first drug approved by the FDA for the treatment of patients with Myelodysplastic Syndromes (MDS). The FDA approved Vidaza, the first in a new class of drugs called demethylation agents, for treatment of all five MDS subtypes. These subtypes include: refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) if accompanied by neutropenia or thrombocytopenia or requiring transfusions; refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL).

Vidaza is believed to exert its antineoplastic effects by causing hypomethylation of DNA and direct cytotoxicity on abnormal hematopoietic cells in the bone marrow. The concentration of Vidaza required for maximum inhibition of DNA methylation in vitro does not cause major suppression of DNA synthesis. Hypomethylation may restore normal function to genes that are critical for differentiation and proliferation. The cytotoxic effects of Vidaza cause the death of rapidly dividing cells, including cancer cells that are no longer responsive to normal growth control mechanisms. Non- proliferating cells are relatively insensitive to Vidaza. Vidaza was approved for IV administration in January 2007.

About Epigenetic Therapy

DNA methylation and
'/>"/>

SOURCE Pharmion Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Pharmion and GPC Biotech Announce Results of Overall Survival Analysis From the Satraplatin Pivotal Phase 3 Trial
2. Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology (ASH) Annual Meeting
3. Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting
4. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
5. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
6. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
7. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
8. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
9. AtriCure to Present at Roth Capital Partners 2007 New York Conference
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. MDS to Present at Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 23, 2014 A classic black prom dress ... most famous dress suppliers, has unveiled its new items of ... are now offered at a big discount, up to 70% ... , The new black prom dresses, made with the ... meet the needs of all customers, the company provides these ...
(Date:11/22/2014)... Today, Dylan Queen, a renowned brand in ... dresses; the business offers a wide range of special ... worldwide, allowing them to create multiple looks easily. , ... new collection of chic wedding dresses has been prepared ... at discounted rates now. Dylan Queen can always create ...
(Date:11/22/2014)... Discount-Dress.com is an important company in the ... increase the company’s online market share by a series of ... dresses and announced a bridesmaid dress promotion for the new ... 2014. All the dresses from this company are not only ... Discount-Dress.com is very good at manufacturing wedding dresses. Customers prefer ...
(Date:11/22/2014)... PITTSBURGH, PA (PRWEB) November 22, 2014 ... about the pain caused by the machine," said an ... injury, she had to go back a second time ... my invention idea." , She developed the patent-pending MAMO ... for breast cancer. The design saves the patient from ...
(Date:11/22/2014)... 22, 2014 (HealthDay News) -- The wide variety and ... a threat for people with food allergies, an expert ... so many types of food allergies that it can ... holidays," Dr. Guha Krishnaswamy, director of allergy and clinical ... a hospital news release. "If you know you ...
Breaking Medicine News(10 mins):Health News:New Black Prom Dresses from BellasDress.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:'Tis the Season of Challenges for Those With Food Allergies 2
... Organization (WHO) it was found that tobacco usage is on ... It said that the industry is luring people and the ... The theme of the World No Tobacco Day states that ... addictive, harmful and can cause death. , Dr ...
... thing in the US of A is the best ... an independent environmental organisation Sierra Club to the tune ... water. They attribute it to the Environmental Protection Agency's ... and seasonal streams. ,Utah (79/2.0/90*), Colorado (68/3.6/83), ...
... diva Elizabeth Taylor took to the airways to try to quash ... ,"Do I look like I'm dying? Do I look like or ... broadcast of CNN's Larry King Live. ,The adamant 74-year-old, ... because of chronic back pain as she answered a range of ...
... in US is all set to use Singapore as a ... from leukaemia// , of the developing Southeast Asian countries. ... to be used in the transplants the children need. ... here," The Straits Times quoted Allen Yeoh, senior consultant at ...
... smoking-related lung damages in healthy smokers//. ,A harmless gas, helium is now ... the University of Wisconsin-Madison finds. MRI (magnetic resonance imaging),a diagnostic technique creates clear and ... images. ... ...
... survey on NHS hospitals revealed falling standards of cleanliness ... ,Comparing to 56 percent people in 2002, only 52 ... in 2003 said lavatories were very clean, but only ... NHS patients' survey reported high levels of general satisfaction ...
Cached Medicine News:Health News:Drinking water in America not all that safe: says report 2Health News:Helium And MRI Scanning Clearly Detects Smoker Lungs – Research Find 2
(Date:11/21/2014)... 2014 In September 2014, the staff at ... a new product development plan that started with the ... lab coat , aptly named "Vera G.," after ... the world. The new women,s designer lab coat is ... sleek envelope collar, vertical princess and high waist seaming, ...
(Date:11/21/2014)... N.J. , Nov. 21, 2014  PTC Therapeutics, Inc. ... the 2014 Legend of Technology Award for Vision, Innovation, and ... Ph.D., Chief Executive Officer. This award recognizes an individual who ... New Jersey for several decades. ... Technology Award," stated Stuart Peltz , Ph.D., CEO of ...
(Date:11/21/2014)... , Nov. 20, 2014  Market research firm Kalorama information ... of The Buy, in the medical device industry.  The ... devices will produce just 3% growth this year, which ... acquisitions of product lines and entrance by acquisition into ... of medical devices, The Global Market for Medical ...
Breaking Medicine Technology:Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2
... Aug. 17 In response to unprecedented devastation and human ... Foundations today announced it would give an additional $5 million ... "We need everyone to pitch in to the ... Open Society Foundation in Pakistan – FOSI-Pakistan. "While the government ...
... FEICHENG, China, Aug. 17 /PRNewswire-Asia-FirstCall/ -- ... ... var shortURL ... by longUrl, so we need to grab the first one. for (var r in data.results) { ...
Cached Medicine Technology:George Soros to Boost Civil Society Response in Flood Affected Areas of Pakistan 2China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 2China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 3China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 4China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 5China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 6China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 7China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 8China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 9China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 10China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 11China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 12China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 13China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 14China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 15
... BloodTrack Courier* controls and monitors the ... of hospital refrigerators. BloodTrack Courier provides a ... your hospital network. , BloodTrack Courier electronically ... hospital environment, from its receipt of blood ...
Lasts up to 3 months , Absorbable copolymer of glycolic acid and trimethylene carbonate , Designed to provide relief from short term dry eye conditions. , Appropriate for surgery-related d...
... Proclear Multifocal are the only contact ... experienced by those with aging eyes: presbyopia ... lenses combine a superior lens design, Balanced ... made using our patented PC Technology. The ...
... Accommodating Intraocular Lens is for the treatment of ... many middle aged and older patients. , Presbyopia ... the natural lens of the eye as a ... elastic. With less elasticity, the eye has a ...
Medicine Products: